|
Basis of Presentation and Significant Accounting Policies (Details Textual) (USD $)
|
3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 6 Months Ended | 12 Months Ended | 3 Months Ended | 6 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2014
|
Jun. 30, 2013
|
Dec. 31, 2013
|
Jun. 30, 2014
Cost of Sales [Member]
|
Jun. 30, 2013
Cost of Sales [Member]
|
Jun. 30, 2014
Cost of Sales [Member]
|
Jun. 30, 2013
Cost of Sales [Member]
|
Jun. 30, 2014
Customer Concentration Risk [Member]
|
Dec. 31, 2013
Customer Concentration Risk [Member]
|
Jun. 30, 2014
Accounts Receivable [Member]
|
Dec. 31, 2013
Accounts Receivable [Member]
|
Jun. 30, 2014
Fulton Bank [Member]
|
Jun. 30, 2014
Bank of America [Member]
|
Dec. 31, 2013
Bank of America [Member]
|
Jun. 30, 2014
Rapid Enzymatic Assay [Member]
|
Jun. 30, 2014
Maximum [Member]
|
Jun. 30, 2014
Maximum [Member]
Patents [Member]
|
|
| Allowance for Doubtful Accounts Receivable | $ 0 | $ 0 | $ 0 | ||||||||||||||||
| Allowance for Doubtful Accounts Receivable, Write-offs | 0 | 0 | 0 | 0 | |||||||||||||||
| Cash, FDIC Insured Amount | 250,000 | ||||||||||||||||||
| Cash | 393,894 | 4,282 | 99,418 | ||||||||||||||||
| Concentration Risk, Percentage | 87.00% | 85.00% | 97.00% | 97.00% | |||||||||||||||
| Shipping, Handling and Transportation Costs | 8,999 | 12,186 | 17,237 | 22,584 | 18,170 | 23,719 | 29,207 | 58,722 | |||||||||||
| Revenue from Related Parties | $ 0 | $ 631,518 | $ 766,379 | $ 1,551,340 | $ 864,000 | ||||||||||||||
| Finite-Lived Intangible Asset, Useful Life | 17 years | ||||||||||||||||||